Thoracic Transplant Recipient Registration (TRR) Record Field Descriptions
The Transplant Recipient Registration (TRR) records are generated and available immediately after a transplant event is reported through the recipient feedback process in WaitlistSM. A TRR will also be generated in the case of a living donor transplant, where a recipient was added through the donor feedback process in Tiedi®. The TRR record is completed by the transplant center performing the transplant. The registration and hospital discharge follow-up information is combined in this record.
Complete the TRR at hospital discharge or six weeks post transplant, whichever is first. If the recipient is still hospitalized at six weeks post transplant, provide the most recent information available regarding the recipient's progress.
The TRR record must be completed within 60 days from the record generation date. See OPTN Policy for additional information. Use the search feature to locate specific policy information on Data Submission Requirements.
To correct information that is already displayed on an electronic record, call the UNetSM Help Desk at 1-800-978-4334.
Recipient Information
Name: Verify the last name, first name and middle initial of the transplant recipient is correct. If the information is incorrect, corrections may be made on the recipient's TCR record.
DOB: Verify the displayed date is the recipient's date of birth. If the information is incorrect, corrections may be made on the recipient's TCR record.
SSN: Verify the recipient's social security number is correct. If the information is incorrect, contact the Help Desk at 1-800-978-4334.
Gender: Verify the recipient's gender is correct. If the information is incorrect, corrections may be made on the recipient's TCR record.
HIC: Verify the 9 to 11 character Health Insurance Claim number for the recipient indicated on the recipient's most recently updated TCR record is correct. If the recipient does not have a HIC number, you may leave this field blank.
Tx Date: Verify the displayed transplant date is the date of the beginning of the first anastomosis. If the operation started in the evening and the first anastomosis began early the next morning, the transplant date is the date that the first anastomosis began. The transplant is considered complete when the cavity is closed and the final skin stitch/staple is applied. The transplant date is indicated immediately after a transplant event is reported through the recipient feedback process in Waitlist and in the case of a living donor transplant, where a recipient was added through the donor feedback process in Tiedi.
State of Permanent Residence: Select the name of the state of the recipient's permanent address at the time of transplant (location of full-time residence, not transplant center location). This field is required. (List of State codes – See Appendix A)
Permanent Zip Code: Enter the recipient's permanent zip code at the time of transplant (location of full-time residence, not transplant center location). This field is required.
Provider Information
Recipient Center: The Recipient Center information reported in Waitlist displays. Verify that the center information is the hospital where the transplant operation was performed. The Provider Number is the 6-character Medicare identification number of the hospital. This is followed by the Center Code and Center Name.
Physician Name: Enter the name of the physician who is following the patient. This field is required.
Physician NPI #: Enter the 10-character CMS (Center for Medicare and Medicaid Services) assigned National Provider Identifier of the transplant physician. Your hospital billing office may be able to obtain this number for you. This field is required.
Surgeon Name: Enter the name of the primary surgeon, who performed the transplant operation, and under whose name the transplant is billed. This field is required.
Surgeon NPI #: Enter the 10-character CMS (Center for Medicare and Medicaid Services) assigned National Provider Identifier of the transplant surgeon. Your hospital billing office may be able to obtain this number for you. This field is required.
Donor Information
UNOS Donor ID #: The UNOS Donor ID number, reported in the Recipient Feedback, will display. Each potential donor is assigned an identification number by OPTN/UNOS. This ID number corresponds to the date the donor information was entered into the OPTN/UNOS computer system.
Donor Type: The donor type, reported in the Recipient Feedback, will display. Verify the recipient's donor type is correct. If the information is incorrect, contact the Help Desk at 1-800-978-4334.
Deceased
indicates the donor was not living at the time of donation.
Living
indicates the donor was living at the time of donation.
Patient Status
Primary Diagnosis: Select the primary diagnosis for the disease requiring a transplant for this recipient. If the recipient has had a previous transplant for the same organ type, enter Retransplant/Graft Failure as the primary diagnosis for that organ. If Other, Specify is selected, enter the primary diagnosis in the space provided. This field is required. (List of Thoracic Diagnosis codes – See Appendix F).
Date: Last Seen, Retransplanted, or Death: Complete at discharge (if discharged prior to six weeks from transplant date) or at six weeks from transplant date, whichever occurs first. Enter the date the hospital reported the recipient as living, retransplanted (when the data was obtained prior to the recipient's discharge) or the date of the recipient's death, using the standard 8-digit numeric format of MM/DD/YYYY. This field is required.
Patient Status: Complete at discharge (if discharged prior to six weeks from transplant date) or at six weeks from transplant date, whichever occurs first. Select the appropriate status for this recipient. If Dead is selected, indicate the cause of death. This field is required.
Living
Dead
Retransplanted
Primary Cause of Death: If the Patient Status is Dead, select the patient's cause of death. If an Other code is selected, enter the other cause of death in the space provided. (List of Primary Cause of Death codes – See Appendix M)
Contributory Cause of Death: If the Patient Status is Dead, select the patient's contributory cause of death. If an Other code is selected, enter the other cause of death in the space provided. (List of Contributory Cause of Death codes – See Appendix M)
Contributory Cause of Death: If the Patient Status is Dead, select the patient's contributory cause of death. If an Other code is selected, enter the other cause of death in the space provided. (List of Contributory Cause of Death codes – See Appendix M)
Note: If the patient is being retransplanted, access the patient's last record for their previous transplant and select Retransplanted in the Patient Status field. This will stop the generation of TRF records associated with the previous transplant.
Transplant Hospitalization:
Date of Admission to Tx Center: Enter the date the recipient was admitted to the transplant center, using the 8-digit MM/DD/YYYY format. If the patient was admitted to the hospital before it was determined a transplant was needed, enter the date it was determined the patient needed a transplant. This field is required.
Date of Discharge From Tx Center: Enter the date the recipient was released to go home, using the 8-digit MM/DD/YYYY format. The recipient's hospital stay includes total time spent in different units of the hospital, including medical and rehab. This information is not required in the TRR record, but if entered here, it will automatically fill in the future TRF records. It is required in the TRF record.
Note: Leave this field blank if the recipient was removed from the waiting list with a code of 21, indicating the recipient died during the transplant procedure.
Medical Condition at time of transplant: Select the choice that best describes the recipient's condition and location just prior to the time of transplant. This field is required.
In
Intensive Care Unit
Hospitalized Not in ICU
Not
Hospitalized
Patient on Life Support: If the recipient was on life support at the time of transplant, select Yes. If not, select No. If Yes is selected, select life support types that apply. If Other Mechanism is selected, enter the type of mechanism in the space provided. This field is required.
(Heart Only)
Extra
Corporeal Membrane Oxygenation
Intra Aortic Balloon
Pump
Prostaglandins
Intravenous Inotropes
Inhaled
NO
Ventilator
- Select only if the recipient is on continuous invasive
ventilation.
Other
mechanism
(Lung and Heart/Lung Only)
Extra
Corporeal Membrane Oxygenation
Intra Aortic Balloon
Pump
Prostacyclin Infusion
Prostacyclin Inhalation
Inhaled
NO
Ventilator -
Select only if the recipient was on continuous invasive
ventilation.
IV
Inotropes
(pediatric
recipients only)
Other
Mechanism
Patient on Ventricular Assist Device: If the candidate was on a Ventricular Assist Device (VAD) at the time of transplant, select the type. If the candidate was not on a VAD, select None. This field is required (List of Device Type codes See Appendix B)
If a VAD was indicated, select the brand of device that the candidate was on. If LVAD+RVAD was indicated, select the brand of device the candidate was on for both LVAD and RVAD. If Other, Specify is selected for one of the following, specify the name in the space provided.
LVAD:
Abiomed
AB5000
Abiomed
BVS 5000
Berlin Heart EXCOR
Biomedicus
Cardiac Assist
Tandem Heart
CentriMag
(Thoratec/Levitronix)
Evaheart
Heartmate
II
Heartmate XVE
Heartsaver VAD
Heartware HVAD
Impella
Recover 2.5
Impella Recover 5.0
Jarvik 2000
Maquet
Josta Rotaflow
Medos
MicroMed DeBakey
MicroMed DeBakey
- Child
PediMag
(Thoratec/Levitronix)
Terumo DuraHeart
Thoratec
IVAD
Thoratec PVAD
Toyobo
Ventracor
VentrAssist
Worldheart Levacor
Other, Specify
RVAD:
Abiomed
AB5000
Abiomed
BVS 5000
Berlin Heart EXCOR
Biomedicus
Cardiac Assist
Tandem Heart
CentriMag
(Thoratec/Levitronix)
Evaheart
Heartmate
II
Heartmate XVE
Heartsaver VAD
Heartware HVAD
Impella
Recover 2.5
Impella Recover 5.0
Jarvik 2000
Maquet
Josta Rotaflow
Medos
MicroMed DeBakey
MicroMed DeBakey
- Child
PediMag
(Thoratec/Levitronix)
Terumo DuraHeart
Thoratec
IVAD
Thoratec PVAD
Toyobo
Ventracor
VentrAssist
Worldheart Levacor
Other, Specify
TAH:
AbioCor
SynCardia
CardioWest
Other, Specify
LVAD + RVAD: (List of LVAD codes – See Appendix C) (List of RVAD codes – See Appendix D)
Functional Status: Select the choice that best describes the recipient's functional status just prior to the time of transplant. This field is required.
Note: The Karnofsky Index will display for adults aged 18 and older.
100% - Normal, no complaints, no evidence of disease
90% - Able to carry on normal activity: minor symptoms of disease
80% - Normal activity with effort: some symptoms of disease
70% - Cares for self: unable to carry on normal activity or active work
60% - Requires occasional assistance but is able to care for needs
50% - Requires considerable assistance and frequent medical care
40% - Disabled: requires special care and assistance
30% - Severely disabled: hospitalization is indicated, death not imminent
20% - Very sick, hospitalization necessary: active treatment necessary
10% - Moribund, fatal processes progressing rapidly
Note: The Lansky Score will display for pediatrics aged less than 18.
100% - Fully active, normal
90% - Minor restrictions in physically strenuous activity
80% - Active, but tires more quickly
70% - Both greater restriction of and less time spent in play activity
60% - Up and around, but minimal active play; keeps busy with quieter activities
50% - Can dress but lies around much of day; no active play; can take part in quiet play/activities
40% - Mostly in bed; participates in quiet activities
30% - In bed; needs assistance even for quiet play
20% - Often sleeping; play entirely limited to very passive activities
10% - No play; does not get out of bed
Not Applicable (patient < 1 year old)
Unknown
Note: This evaluation should be in comparison to the person's normal function, indicating how the patient's disease has affected their normal function.
Cognitive Development: (This field is required for recipients 18 years of age or younger.) Select the choice that best describes the recipient's cognitive development just prior to the time of transplant.
Definite Cognitive Delay/Impairment (verified by IQ score <70 or unambiguous behavioral observation)
Probable Cognitive Delay/Impairment (not verified or unambiguous but more likely than not, based on behavioral observation or other evidence)
Questionable Cognitive Delay/Impairment (not judged to be more likely than not, but with some indication of cognitive delay/impairment such as expressive/receptive language and/or learning difficulties)
No Cognitive Delay/Impairment (no obvious indicators of cognitive delay/impairment)
Not Assessed
Motor Development: (This field is required for recipients 18 years of age or younger.) Select the choice that best describes the recipient's motor development just prior to the time of transplant.
Definite Motor Delay/Impairment (verified by physical exam or unambiguous behavioral observation)
Probable Motor Delay/Impairment (not verified or unambiguous but more likely than not, based on behavioral observation or other evidence)
Questionable Motor Delay/Impairment (not judged to be more likely than not, but with some indication of motor delay/impairment)
No Motor Delay/Impairment (no obvious indicators of motor delay/impairment)
Not Assessed
Working for income: (This field is required for recipients 18 years of age or older.) If the recipient is working for income just prior to the time of transplant, select Yes. If not, select No. If unknown, select UNK.
Academic Progress: (This field is required for recipients less than 18 years of age.) Select the choice that best describes the recipient's academic progress just prior to the time of transplant. If the recipient is less than 5 years old or has graduated from high school, select Not Applicable < 5 years old/High School graduate or GED.
Within
One Grade Level of Peers
Delayed Grade Level
Special
Education
Not Applicable <5 years old/High School graduate or
GED
Status Unknown
Academic Activity Level: (This field is required for recipients less than 18 years of age.) Select the choice that best describes the recipient's academic activity level just prior to the time of transplant. If the recipient is less than 5 years old or has graduated from high school, select Not Applicable < 5 years old/High School graduate or GED.
Full
academic load
Reduced academic load
Unable to participate
in academics due to disease or condition
Not Applicable <5
years old/High School graduate or GED
Status Unknown
Source of Payment:
Primary: Select as appropriate to indicate the recipient's source of primary payment (largest contributor) for the transplant. This field is required.
Private insurance refers to funds from agencies such as Blue Cross/Blue Shield, etc. It also refers to any worker's compensation that is covered by a private insurer.
Public insurance - Medicaid refers to state Medicaid funds.
Public insurance - Medicare FFS (Fee-for-Service) refers to funds, from the government in which doctors and other health care providers are paid for each service provided to a recipient. For additional information about Medicare, see http://www.medicare.gov/Choices/Overview.asp.
Public insurance - Medicare & Choice (also known as Medicare Managed Care) refers to funds from the government in which doctors and other health care providers are paid for each service provided to a recipient, along with additional benefits such as coordination of care or reducing-out-of-pocket expenses. Sometimes a recipient may receive additional benefits such as prescription drugs. For additional information about Medicare, see http://www.medicare.gov/Choices/Overview.asp.
Public insurance - CHIP (Children's Health Insurance Program)
Public insurance - Department of VA refers to funds from the Veterans Administration.
Public insurance - Other government
Self indicates that the recipient will pay for the cost of transplant.
Donation indicates that a company, institution, or individual(s) donated funds to pay for the transplant and care of the recipient.
Free Care indicates that the transplant hospital will not charge recipient for the costs of the transplant operation.
Foreign Government, Specify refers to funds provided by a foreign government (Primary only) Specify foreign country in the space provided. (List of Foreign Country codes – See Appendix E)
Clinical Information: Pretransplant
Date of Measurement: (Complete for recipients 18 years of age or younger.) Enter the date, using the 8-digit format of MM/DD/YYYY, the recipient’s height and weight were measured.
Height: Enter the height of the recipient, just prior to the time of transplant, in feet and inches or centimeters. If the recipient’s height is unavailable, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). For recipients 18 years old or younger at the time of transplant, UNet will generate and display calculated percentiles based on the 2000 CDC growth charts. This field is required.
Weight: Enter the weight of the recipient, just prior to the time of transplant, in pounds or kilograms. If the recipient’s weight is unavailable, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). For recipients 18 years old or younger at the time of transplant, UNet will generate and display calculated percentiles based on the 2000 CDC growth charts. This field is required.
BMI (Body Mass Index): The recipient's BMI will display. For candidates less than 20 years of age at the time of transplant, UNet will generate and display calculated percentiles based on the 2000 CDC growth charts.
Percentiles are the most commonly used clinical indicator to assess the size and growth patterns of individual children in the United States. Percentiles rank the position of an individual by indicating what percent of the reference population the individual would equal or exceed (i.e. on the weight-for-age growth charts, a 5 year-old girl whose weight is at the 25th percentile, weighs the same or more than 25 percent of the reference population of 5-year-old girls, and weighs less than 75 percent of the 5-year-old girls in the reference population). For additional information about CDC growth charts, see http://www.cdc.gov/.
Note: Users who check the BMI percentiles against the CDC calculator may notice a discrepancy that is caused by the CDC calculator using 1 decimal place for height and weight and UNet using 4 decimal places for weight and 2 for height.
Previous Transplants: The three most recent transplant(s), indicated on the recipient's validated Transplant Recipient Registration (TRR) record(s), will display. Verify all previous transplants listed by organ type, transplant date and graft failure date.
Note: The three most recent transplants on record for this recipient will be displayed for verification. If there are any prior transplants that are not listed here, contact the UNet Help Desk at 1-800-978-4334 or [email protected] to determine if the transplant event is in the database.
Viral Detection:
HIV Serostatus: Select the serology results from the drop-down list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: Human Immunodeficiency Virus - Any of several retroviruses and especially HIV-1 that infect and destroy helper T cells of the immune system causing the marked reduction in their numbers that is diagnostic of AIDS.
CMV Status: Select the serology results from the drop-down list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
HBV Core Antibody: Select the serology results from the drop-down list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: Hepatitis B Virus - A sometimes fatal hepatitis caused by a double-stranded DNA virus (genus Orthohepadnavirus of the family Hepadnaviridae) that tends to persist in the blood serum and is transmitted especially by contact with infected blood (as by transfusion or by sharing contaminated needles in illicit intravenous drug use) or by contact with other infected bodily fluids (as during sexual intercourse) -- also called serum hepatitis.
HBV Surface Antibody Total: Select the serology results from the drop-down list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
HBV Surface Antigen: Select the serology results from the drop-down list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: Hepatitis B Virus - A sometimes fatal hepatitis caused by a double-stranded DNA virus (genus Orthohepadnavirus of the family Hepadnaviridae) that tends to persist in the blood serum and is transmitted especially by contact with infected blood (as by transfusion or by sharing contaminated needles in illicit intravenous drug use) or by contact with other infected bodily fluids (as during sexual intercourse) -- also called serum hepatitis.
HCV Serostatus: Select the serology results from the drop-down list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: Hepatitis C Virus - A disease caused by a flavivirus that is usually transmitted by parenteral means (as injection of an illicit drug, blood transfusion, or exposure to blood or blood products) and that accounts for most cases of non-A, non-B hepatitis.
EBV Serostatus: Select the serology results from the drop-down list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: (Epstein-Barr Virus) - A herpesvirus (genus Lymphocryptovirus) that causes infectious mononucleosis and is associated with Burkitt's lymphoma and nasopharyngeal carcinoma -- abbreviation EBV; called also EB virus.
Most recent Hemodynamics: Enter the most recent hemodynamic values. For each measure, indicate if the measurement was obtained while the recipient was on Inotropes or Vasodilators. If the tests were not done, select Not Done in the ST field (Missing, Unknown, N/A, Not Done).
PA (sys) mm/Hg - systolic pulmonary artery pressure This field is required.
PA (dia) mm/Hg - diastolic pulmonary artery pressure This field is required.
PA (mean) mm/Hg - mean pulmonary artery pressure This field is required.
PCW (mean) mm/Hg - mean pulmonary capillary wedge pressure This field is required.
CO L/min - cardiac output This field is required.
Cardiac Index will be calculated and displayed for pediatric recipients.
Most recent Serum Creatinine: Enter the most recent pre-transplant serum creatinine lab value in mg/dl. If the value is not available, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). This field is required.
Most recent Serum Total Bilirubin: Enter the most recent pre-transplant serum total bilirubin lab value in mg/dl. If the value is not available, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). This field is required.
Chronic Steroid Use: If the recipient required chronic steroid use prior to transplantation, select Yes. If not, select No. If unknown, select UNK. This field is required.
Pulmonary Status (Lung and Heart/Lung Only): (Give most recent value) Enter the most recent pulmonary function values. If the values are not available, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done).
FVC - forced vital capacity (% predicted) This field is required.
FeV1 - forced expiratory volume at one second (% predicted) This field is required.
pCO2 - partial carbon dioxide pressure This field is required.
Events occurring between listing and transplant: For each of the events listed, indicate if the event occurred between listing and transplant.
Transfusions: If the recipient received any blood or blood product transfusions between listing and transplant, select Yes. If not, select No. If unknown, select UNK. This field is required.
Pulmonary Embolism: (Lung only) If the recipient has experienced any episode of pulmonary embolism between listing and transplant, select Yes. If not, select No. If unknown, select UNK. This field is only required for lung recipients younger than 18 years old.
Infection Requiring IV Therapy within 2 wks prior to Tx: If the recipient experienced any infection requiring treatment with intravenous antibiotics during the two week period immediately prior to transplantation, select Yes. If not, select No. If unknown, select UNK. This field is required.
Dialysis: If the recipient had any hemodialysis or peritoneal dialysis between listing and transplant, select Yes. If not, select No. If unknown, select UNK. This field is required.
Prior Cardiac Surgery (non-transplant): If the recipient had cardiac surgery between listing and transplant, select Yes. If no prior cardiac surgery, select No. If Yes is selected, select all type(s) of surgery. If the type of cardiac surgery is not listed, select Other, specify and enter the type of cardiac surgery in the space provided. This field is required.
CABG
Valve
Replacement/Repair
Congenital
Left Ventricular
Remodeling
Other, specify
Prior Lung Surgery (non-transplant): If the recipient had lung surgery between listing and transplant, select Yes. If no prior lung surgery, select No. If Yes is selected, select all type(s) of surgery. If the type of lung surgery is not listed, select Other, specify and enter the type of lung surgery in the space provided. This field is required.
Pneumoreduction
Pneumothorax
Surgery-Nodule
Pneumothorax
Decortication
Lobectomy
Pneumonectomy
Left
Thoracotomy
Right Thoracotomy
Other, specify
Episode of Ventilatory Support: If the recipient experienced continuous invasive ventilation between listing and transplant, select Yes. If not, select No. If Yes is selected, indicate the most recent timeframe. This field is required.
If yes, indicate most recent timeframe: If the recipient had an episode of ventilator support, select the most recent timeframe.
At
time of transplant
Within 3 months of transplant
> 3
months prior to transplant
Tracheostomy (Lung and Heart/Lung Only): If the recipient had a tracheostomy, select Yes. If not, select No. If unknown, select UNK. This field is required.
[PEDIATRIC RECIPIENTS]
Prior Thoracic Surgery Other Than Prior Transplant: If the recipient had thoracic surgery prior to listing, select Yes. If no prior thoracic surgery, select No. If Yes is selected, select all type(s) of surgery. If the type of thoracic surgery is not listed, select Other, specify and enter the type of thoracic surgery in the space provided.
If yes, number of prior sternotomies (List of Sternotomies codes – See Appendix G)
If yes, number of prior thoracotomies (List of Thoracotomies codes – See Appendix H)
Prior Congenital Cardiac Surgery: If the recipient had prior surgery, select Yes. If not, select No. If unknown, select UNK.
If Yes, palliative surgery: If the surgery was palliative, select Yes. If not, select No. If unknown, select UNK.
If Yes, corrective surgery: If the surgery was corrective, select Yes. If not, select No. If unknown, select UNK.
If Yes, single ventricular physiology: If the surgery was to correct single ventricular physiology, select Yes. If not, select No. If unknown, select UNK.
Previous Pregnancies: (This field will not display for male recipients.) For female recipients, select the number of previous pregnancies. Previous pregnancies include pregnancies, which may not have resulted in live births. If the information is unknown, select Unknown.
No
Previous Pregnancy
1 Previous Pregnancy
2 Previous
Pregnancies
3 Previous Pregnancies
4 Previous Pregnancies
5
Previous Pregnancies
More than 5 Previous Pregnancies
Not
Applicable: < 10 years old
Unknown
Pretransplant Titer Information: Complete if the recipient received an incompatible blood type donor heart.
Most Recent Anti-B Titer: Select the Most Recent Anti-B Titer value, Not taken or Not available if applicable. Enter the Sample Date in mm/dd/yyyy format. The date to be reported is the date when the candidate's blood was drawn.
Note: The Sample Date cannot be greater than 30 days prior to transplant date, cannot be prior to the candidate's date of birth, cannot be a future date and cannot be after the transplant date. This field will only display if the recipient’s ABO blood-type is A or O.
Most Recent Anti-A Titer: Select the Most Recent Anti-A Titer value, Not taken or Not available if applicable. Enter the Sample Date in mm/dd/yyyy format. The date to be reported is the date when the candidate's blood was drawn.
Note: The Sample Date cannot be greater than 30 days prior to transplant date, cannot be prior to the candidate's date of birth, cannot be a future date and cannot be after the transplant date. This field will only display if the recipient’s ABO blood-type is B or O.
Clinical Information – Transplant Procedure
Multiple Organ Recipient: If the recipient received other organs, reported on the Recipient Feedback, they will display. If the recipient didn't receive any other organs at this time, None is displayed. Verify the other organs, transplanted at this time, are correct. If incorrect, contact the Help Desk.
Were extra vessels used in the tx procedure: If extra vessels (vascular allografts) were used in the transplant procedure, as indicated on the Waitlist Removal, YES displays.
Vessel Donor ID: The Donor ID entered on the Waitlist Removal displays.
Note: Donor IDs entered for this question must be from deceased donors. All deceased donor extra vessels must be
monitored due to the potential for disease transmission.
Note: If the extra vessels used in a transplant procedure are procured from a tissue processing organization, they are not reported in UNet.
Procedure Type: The procedure type, reported on the Recipient Feedback, will display. Verify the information displayed in the Procedure Type field is correct.
Heart
Heart/Lung
Procedure Information (Heart Only): For heart recipients, select the appropriate procedure information. This field is required.
Orthotopic Bicaval: Superior and inferior venacaval anastomoses.
Orthotopic Traditional: Right and left atrial anastomoses.
Orthotopic Total (Bicaval, PV): Orthotopic bicaval anastomoses plus pulmonary vein anastomosis.
Heterotopic: The recipient's native heart was not removed.
Procedure Information (Heart/Lung):
The recipient received an en-bloc heart lung transplant.
Procedure Information (Lung Only):
Single Left Lung: The recipient received a single left lung.
Single Right Lung: The recipient received a single right lung.
Bilateral Sequential Lung: The recipient received both lungs from a single donor, which were transplanted sequentially. Ischemic times should be reported for both lungs.
En-Block Double Lung: The recipient received both lungs from the same donor, which were transplanted en-bloc or together. One Ischemic times should be reported for both lungs.
Lobe, Right: The recipient received a single right lobe.
Lobe, Left: The recipient received a single left lobe.
Was this a retransplant due to failure of a previous thoracic graft: If the recipient is now receiving a new thoracic transplant due to failure of a previous transplant, select Yes. If not, select No.
Total Organ Ischemia Time (include cold, warm and anastomotic time): Enter the total ischemia time, for the organ, in minutes. If the time is unavailable, select the status from the ST field (Missing, Unknown, N/A, Not Done).
Clinical Information: Post Transplant
Graft Status: If the graft is functioning, select Functioning. If the graft is not functioning at the time of hospital discharge or time of report, select Failed. If Failed, complete the remainder of this section. This field is required.
Note: If death is indicated for the recipient, and the death was a result of some other factor unrelated to graft failure, select Functioning.
If Failed, provide the following information:
Date of Failure: Enter the date of graft failure using the standard 8-digit numeric format of MM/DD/YYYY.
Primary Cause of Graft Failure: Select the cause of graft failure.
Primary
Non-Function
Acute Rejection
Chronic
Rejection/Atherosclerosis
Other, Specify
Post Transplant Titer Information: Complete if the recipient received an incompatible blood type donor heart and death or graft failure is reported on the TRR:
Most Recent Anti-B Titer: Select the Most Recent Anti-B Titer value, Not taken or Not available if applicable. Enter the Sample Date in mm/dd/yyyy format. The date to be reported is the date when the candidate's blood was drawn.
Note: The Sample Date cannot be prior to the recipient's transplant date, cannot be after the graft failure or the death date and cannot be a future date. This field will only display if the recipient’s ABO blood-type is A or O.
Most Recent Anti-A Titer: Select the Most Recent Anti-A Titer value, Not taken or Not available if applicable. Enter the Sample Date in mm/dd/yyyy format. The date to be reported is the date when the candidate's blood was drawn.
Note: The Sample Date cannot be prior to the recipient's transplant date, cannot be after the graft failure or the death date and cannot be a future date. This field will only display if the recipient’s ABO blood-type is B or O.
Events Prior to Discharge: For each of the events listed indicate if the event occurred during the post-transplant hospital course prior to discharge.
Stroke: If the recipient experienced a stroke (CVA) following the transplant, select Yes. If not, select No. If unknown, select UNK. This field is required.
Dialysis: If the recipient needed to have peritoneal or hemodialysis following the transplant, select Yes. If not, select No. If unknown, select UNK. This field is required.
Ventilator support (Lung and Heart/Lung Only): If recipient did not receive ventilator support, select No. If the recipient received ventilator support, select the duration. If ventilator support status is unknown, select Unknown Status. If the recipient received ventilator support, indicate the duration of the their ventilator support. If the duration is unknown, select Ventilator support, duration unknown. This field is required.
Ventilator
support for <= 48 hours
Ventilator support for > 48 hours
but < 5 days
Ventilator support >= 5 days
Ventilator
support, duration unknown
Unknown Status
Reintubated (Lung and Heart/Lung Only): If the recipient was reintubated, select Yes. If not, select No. If unknown, select UNK. This field is required.
Permanent Pacemaker: If the recipient needed a permanent pacemaker implantation during the initial hospitalization following the transplant operation, select Yes. If not, select No. If unknown, select UNK. This field is required.
Airway Dehiscence: If the recipient developed an airway dehiscence during the initial hospitalization following the transplant operation, select Yes. If not, select No. If unknown, select UNK. This field is required.
Did patient have any acute rejection episodes between transplant and discharge: If the recipient had any acute rejection episodes between transplant and discharge, select a Yes choice. If not, select No. If a Yes choice is selected, then indicate if a biopsy was done to confirm acute rejection. This field is required.
Yes,
at least one episode treated with anti-rejection agent
Yes, none
treated with additional anti-rejection agent
No
Components of ISHLT primary graft dysfunction (PGD) grade:
Intubated at 72 hours: If not, select NO. If unknown, select UNK.
Pa02 at 72 hours: Either the actual value or the status field must be provided. Missing, Unknown, N/A, Not Done
Fi02 at 72 hours: Either the actual value or the status field must be provided. Missing, Unknown, N/A, Not Done
ECMO a 72 hours: If not, select NO. If unknown, select UNK.
Inhaled NO at 72 hours: If not, select NO. If unknown, select UNK.
Immunosuppressive Information
Are any medications given currently for maintenance or anti-rejection: If medications have been given to the recipient for maintenance or anti-rejection during the time between transplant and hospital discharge, or 6 weeks post-transplant if the recipient has not been discharged, select Yes. If not, select No. If Yes, complete the sections below. This field is required.
Immunosuppressive Medications
For each of the immunosuppressive medications listed, select Ind.(Induction), Maint (Maintenance) or AR (Anti-rejection) to indicate all medications that were prescribed for the recipient during the initial transplant hospitalization period, and for what reason. If a medication was not given, leave the associated box blank.
Induction (Ind.) immunosuppression includes all medications given for a short finite period in the perioperative period for the purpose of preventing acute rejection. Though the drugs may be continued after discharge for the first 30 days after transplant, it will not be used long-term for immunosuppressive maintenance. Induction agents are usually polyclonal, monoclonal, or IL-2 receptor antibodies (e.g., Methylprednisolone, Atgam, Thymoglobulin, OKT3, Simulect, or Zenapax). Some of these drugs might be used for another finite period for rejection therapy and would be recorded as rejection therapy if used for this reason. For each induction medication indicated, enter the total number of days the drug was actually administered in the space provided. For example, if Simulect or Zenapax was given in 2 doses a week apart then the total number of days would be 2, even if the second dose was given after the patient was discharged.
Maintenance (Maint) includes all immunosuppressive medications given before, during or after transplant for varying periods of time which may be either long-term or intermediate term with a tapering of the dosage until the drug is either eliminated or replaced by another long-term maintenance drug (e.g., Prednisone, Cyclosporine, Tacrolimus, Mycophenolate Mofetil, Azathioprine, or Rapamycin). This does not include any immunosuppressive medications given to treat rejection episodes, or for induction.
Anti-rejection (AR) immunosuppression includes all immunosuppressive medications given for the purpose of treating an acute rejection episode during the initial post-transplant period or during a specific follow-up period, usually up to 30 days after the diagnosis of acute rejection (e.g., Methylprednisolone, Atgam, OKT3, or Thymoglobulin). When switching maintenance drugs (e.g., from Tacrolimus to Cyclosporine; or from Mycophenolate Mofetil to Azathioprine) because of rejection, the drugs should not be listed under AR immunosuppression, but should be listed under maintenance immunosuppression.
Note: As further clarification, drugs that are used with the intention to maintain recipients long-term are medications such as Tacrolimus, Cyclosporine, Azathioprine, Mycophenolate Mofetil and Prednisone. These maintenance medications should not be listed as AR medications to treat acute rejection. When patients have a true acute rejection, they are given anti-rejection medication such as steroids, OKT3, ATG, Simulect and Zenapax, in addition to the maintenance medications. These are the medications that should be selected as anti-rejection.
If an immunosuppressive medication other than those listed is being administered (e.g., new monoclonal antibodies), select Ind., Maint, or AR next to Other Immunosuppressive Medication field, and enter the full name of the medication in the space provided. Do not list non-immunosuppressive medications.
If the number of days is unavailable, select the appropriate status from the applicable Status field (Missing, Unknown, N/A, Not Done).
Other Immunosuppressive Medications
For each of the immunosuppressive medications listed, select Ind.(Induction), Maint (Maintenance) or AR (Anti-rejection) to indicate all medications that were prescribed for the recipient during the initial transplant hospitalization period, and for what reason. If a medication was not given, leave the associated box blank.
Induction (Ind.) immunosuppression includes all medications given for a short finite period in the perioperative period for the purpose of preventing acute rejection. Though the drugs may be continued after discharge for the first 30 days after transplant, it will not be used long-term for immunosuppressive maintenance. Induction agents are usually polyclonal, monoclonal, or IL-2 receptor antibodies (e.g., Methylprednisolone, Atgam, Thymoglobulin, OKT3, Simulect, or Zenapax). Some of these drugs might be used for another finite period for rejection therapy and would be recorded as rejection therapy if used for this reason. For each induction medication indicated, enter the total number of days the drug was actually administered in the space provided. For example, if Simulect or Zenapax was given in 2 doses a week apart then the total number of days would be 2, even if the second dose was given after the patient was discharged.
Maintenance (Maint) includes all immunosuppressive medications given before, during or after transplant for varying periods of time which may be either long-term or intermediate term with a tapering of the dosage until the drug is either eliminated or replaced by another long-term maintenance drug (e.g., Prednisone, Cyclosporine, Tacrolimus, Mycophenolate Mofetil, Azathioprine, or Rapamycin). This does not include any immunosuppressive medications given to treat rejection episodes, or for induction.
Anti-rejection (AR) immunosuppression includes all immunosuppressive medications given for the purpose of treating an acute rejection episode during the initial post-transplant period or during a specific follow-up period, usually up to 30 days after the diagnosis of acute rejection (e.g., Methylprednisolone, Atgam, OKT3, or Thymoglobulin). When switching maintenance drugs (e.g., from Tacrolimus to Cyclosporine; or from Mycophenolate Mofetil to Azathioprine) because of rejection, the drugs should not be listed under AR immunosuppression, but should be listed under maintenance immunosuppression.
Note: As further clarification, drugs that are used with the intention to maintain recipients long-term are medications such as Tacrolimus, Cyclosporine, Azathioprine, Mycophenolate Mofetil and Prednisone. These maintenance medications should not be listed as AR medications to treat acute rejection. When patients have a true acute rejection, they are given anti-rejection medication such as steroids, OKT3, ATG, Simulect and Zenapax, in addition to the maintenance medications. These are the medications that should be selected as anti-rejection.
If an immunosuppressive medication other than those listed is being administered (e.g., new monoclonal antibodies), select Ind., Maint, or AR next to Other Immunosuppressive Medication field, and enter the full name of the medication in the space provided. Do not list non-immunosuppressive medications.
If the number of days is unavailable, select the appropriate status from the applicable Status field (Missing, Unknown, N/A, Not Done).
Investigational Immunosuppressive Medications
For each of the immunosuppressive medications listed, select Ind.(Induction), Maint (Maintenance) or AR (Anti-rejection) to indicate all medications that were prescribed for the recipient during the initial transplant hospitalization period, and for what reason. If a medication was not given, leave the associated box blank.
Induction (Ind.) immunosuppression includes all medications given for a short finite period in the perioperative period for the purpose of preventing acute rejection. Though the drugs may be continued after discharge for the first 30 days after transplant, it will not be used long-term for immunosuppressive maintenance. Induction agents are usually polyclonal, monoclonal, or IL-2 receptor antibodies (example: Methylprednisolone, Atgam, Thymoglobulin, OKT3, Simulect, or Zenapax). Some of these drugs might be used for another finite period for rejection therapy and would be recorded as rejection therapy if used for this reason. For each induction medication indicated, enter the total number of days the drug was actually administered in the space provided. For example, if Simulect or Zenapax was given in 2 doses a week apart then the total number of days would be 2, even if the second dose was given after the patient was discharged.
Maintenance (Maint) includes all immunosuppressive medications given before, during or after transplant for varying periods of time which may be either long-term or intermediate term with a tapering of the dosage until the drug is either eliminated or replaced by another long-term maintenance drug (e.g., Prednisone, Cyclosporine, Tacrolimus, Mycophenolate Mofetil, Azathioprine, or Rapamycin). This does not include any immunosuppressive medications given to treat rejection episodes, or for induction.
Anti-rejection (AR) immunosuppression includes all immunosuppressive medications given for the purpose of treating an acute rejection episode during the initial post-transplant period or during a specific follow-up period, usually up to 30 days after the diagnosis of acute rejection (example: Methylprednisolone, Atgam, OKT3, or Thymoglobulin). When switching maintenance drugs (example: from Tacrolimus to Cyclosporine; or from Mycophenolate Mofetil to Azathioprine) because of rejection, the drugs should not be listed under AR immunosuppression, but should be listed under maintenance immunosuppression.
Note: As further clarification, drugs that are used with the intention to maintain recipients long-term are medications such as Tacrolimus, Cyclosporine, Azathioprine, Mycophenolate Mofetil and Prednisone. These maintenance medications should not be listed as AR medications to treat acute rejection. When patients have a true acute rejection, they are given anti-rejection medication such as steroids, OKT3, ATG, Simulect and Zenapax, in addition to the maintenance medications. These are the medications that should be selected as anti-rejection.
If an immunosuppressive medication other than those listed is being administered (e.g., new monoclonal antibodies), select Ind., Maint, or AR next to Other Immunosuppressive Medication field, and enter the full name of the medication in the space provided. Do not list non-immunosuppressive medications.
If the number of days is unavailable, select the appropriate status from the applicable Status field (Missing, Unknown, N/A, Not Done).
Immunosuppressive Medications
Steroids (Prednisone,Methylprednisolone,Solumedrol,Medrol,Decadron)
Atgam (ATG)
OKT3 (Orthoclone, Muromonab)
Thymoglobulin
Simulect - Basiliximab
Zenapax - Daclizumab
Azathioprine (AZA, Imuran)
EON (Generic Cyclosporine)
Gengraf (Abbott Cyclosporine)
Other generic Cyclosporine, specify brand:
Neoral (CyA-NOF)
Sandimmune (Cyclosporine A)
CellCept (Mycophenolate Mofetil; MMF)
Generic MMF (Generic CellCept)
Prograf (Tacrolimus, FK506)
Generic Tacrolimus (Generic Prograf)
Nulojix (Belatacept)
Astagraf XL (Extended Release Tacrolimus)
Sirolimus (RAPA, Rapamycin, Rapamune)
Myfortic (Mycophenolate Sodium)
Other Immunosuppressive Medications
Campath - Alemtuzumab (anti-CD52)
Cyclophosphamide (Cytoxan)
Leflunomide (LFL, Arava)
Methotrexate (Folex, PFS, Mexate-AQ, Rheumatrex)
Other Immunosuppressive Medication, Specify
Rituximab
Investigational Immunosuppressive Medications
Zortress (Everolimus)
Other Immunosuppressive Medication, Specify
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Author | Carly D. Engelberger |
| File Modified | 0000-00-00 |
| File Created | 2021-01-26 |